ALXO
ALX Oncology Holdings Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.01
−0.99%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-59.4%
Return on equity
-50.3%
Return on assets
-56.6%
Return on invested capital
0.00x
Asset turnover
-$70.8M
Cash from operations
$1.00
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026